Thomas Friedrich Schulz

26PUBLICATIONS
110CO-AUTHORS
Molecular targetsInnate immunityMedical molecular engineering of nucleic acids and proteinsRegenerative medicine (incl. stem cells)Central nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Nov 18, 2025
Toward Anti-Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen.

Aylin Berwanger, Saskia Catherina Stein, Sarah Brandner

|Jul 31, 2025
A critical residue in a conserved RBD epitope determines neutralization breadth of pan-sarbecovirus antibodies with recurring YYDRxxG motifs.

Saskia C Stein, George Ssebyatika, Tim Benecke

|Nov 04, 2024
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation.

Saskia C Stein, Guido Hansen, George Ssebyatika

|May 07, 2024
A comprehensive genetic map of cytokine responses in Lyme borreliosis.

Javier Botey-Bataller, Hedwig D Vrijmoeth, Jeanine Ursinus

|Feb 08, 2024
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor.

Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak

|Feb 07, 2024
Innate immune response to SARS-CoV-2 infection contributes to neuronal damage in human iPSC-derived peripheral neurons.

Vania Passos, Lisa M Henkel, Jiayi Wang

Pageof 5

Frequent Collaborators

5 joint publications

Thomas Krey

4 joint publications

Thomas Pietschmann

2 joint publications

Sandra Koch

2 joint publications

Gisa Gerold